loading

Finanzdaten der Kiora Pharmaceuticals Inc-Aktie (KPRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
66.85%
0.7944
2.3962 2.3304 2.5647 3.6022
Operating Income/Loss
66.85%
-0.7944
-2.3962 -2.3304 -2.5647 -3.6022
Nonoperating Income/Loss
35.26%
0.1781
0.1317 0.2604 0.4062 0.1889
Income/Loss From Continuing Operations Before Tax
72.78%
-0.6163
-2.2645 -2.07 -10.36 -3.4133
Income Tax Expense/Benefit
473.93%
-0.6431
-0.1121 0.123 - -
Income/Loss From Continuing Operations After Tax
101.25%
0.0268
-2.1525 -2.193 -4.2235 -3.4133
Net Income/Loss
101.25%
0.0268
-2.1525 -2.193 -4.2235 -3.4133
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
7.54%
4.2899
3.989 4.217 0.1152 4.215
Diluted Average Shares
9.34%
4.3617
3.989 4.217 0.0322 4.215
Basic Earnings Per Share
101.85%
0.01
-0.54 -0.52 -1.15 -0.81
Diluted Earnings Per Share
101.85%
0.01
-0.54 -0.52 -1.04 -0.81
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):